Pharmacokinetic interactions between herbal remedies and medicinal drugs

Xenobiotica

Volumn 32, Issue 6, 2002, Pages 451-478

  Ioannides, C ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; 6',7' DIHYDROXYBERGAMOTTIN; ALPRAZOLAM; AMITRIPTYLINE; ANGELICA DAHURICA EXTRACT; ANTICOAGULANT AGENT; BERAGMOTTIN; CARBAMAZEPINE; CYCLOSPORIN; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DIGOXIN; DRUG; FUROCOUMARIN DERIVATIVE; GARLIC EXTRACT; GINSENG EXTRACT; GLYCOPROTEIN P; GLYCYRRHIZA EXTRACT; HERBACEOUS AGENT; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; ISOTHIOCYANIC ACID DERIVATIVE; ORAL CONTRACEPTIVE AGENT; PLANT EXTRACT; PROTEINASE INHIBITOR; SALVIA MILTIORRHIZA EXTRACT; SILYBUM MARIANUM EXTRACT; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AREA UNDER THE CURVE; ARTICLE; CRUCIFERA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG METABOLISM; DRUG STRUCTURE; ENZYME INDUCTION; FOOD DRUG INTERACTION; GENE EXPRESSION; GRAFT REJECTION; GRAPEFRUIT JUICE; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; INTESTINE; LIVER; MEDICINAL PLANT; NONHUMAN; ORGAN TRANSPLANTATION; PLANT PRODUCT; PROTEIN EXPRESSION; TEA; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HERB-DRUG INTERACTIONS; HUMANS; PHARMACOKINETICS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; XENOBIOTICS;

ALLIUM SATIVUM; ANGELICA DAHURICA; BRASSICACEAE; CIRSIUM; CITRUS X PARADISI; GLYCYRRHIZA; HYPERICUM; HYPERICUM PERFORATUM; PANAX GINSENG; SALVIA; SALVIA MILTIORRHIZA; SILYBUM MARIANUM;

EID: 0036304016     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250210124147     Document Type: Article

References (178)

1. Cancer chemoprevention by tea polyphenols
2. Drug interactions with grapefruit juice
3. The prevention of cancer
4. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms
5. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: Lack of association with the Ah locus
6. Induction of rat hepatic cytochrome P-450I proteins by the antimutagen anthraflavic acid
7. Role of transport proteins in drug absorption, distribution and excretion
8. Anthraflavic acid is a potent and specific inhibitor of cytochrome P-448 activity
9. Furanocoumarins from the root of Angelica dahurica
10. Grapefruit juice-drug interactions
11. Grapefruit-felodipine interaction: Effect of unprocessed fruit and probable active ingredients
12. Grapefruit juice-felodipine interaction: Effect of naringin and 6′,7′-dihydrobergamottin in humans
13. Interaction of citrus juices with felodipine and nifedipine
14. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17α-ethinyloestradiol
15. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane
16. St. John's wort (Hypericum perforatum L): A review of its chemistry, pharmacology and clinical properties
17. Herbal supplements: A potential for drug interactions in transplant recipients
18. Drug interaction between St. John's wort and cyclosporine
19. Caffeine consumption
20. Furanocoumarins with affinity to brain benzodiazepine receptors in vitro
21. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers
22. Pharmacokinetics: Time-dependent changes - Autoinduction of carbamazepine epoxidation
23. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers
24. Interactions between clinically used drugs and oral contraceptives
25. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites
26. Modulation of rat hepatic microsomal monooxygenase activities and cytotoxicity by diallyl sulfide
27. Profound drop of cyclosporin A whole blood levels caused by St John's wort (Hypericum perforatum)
28. Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans
29. Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea
30. Contribution of caffeine and flavanols in the induction of phase II activities by green tea
31. Cytochrome P450 induction by tea, and its consequences on the bioactivation of chemical carcinogens: Contribution of caffeine and flavanols
32. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures
33. Lack of effect of St. John's wort on carbamazepine pharmacokinetics in healthy volunteers
34. Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins
35. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver
36. Inhibitory effect of methanolic solution of St. John's wort (Hypericum perforatum) on cytochrome P450 3A4 activity in human liver microsomes
37. In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles
38. The effects of danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in the rats
39. Interaction between warfarin and danshen (Salvia miltiorrhiza)
40. Role of cytochrome P450 3A4 in human metabolism of MK-639, a potent human immunodeficiency virus protease inhibitor
41. Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein
42. Structure elucidation of acid reaction products of indole-3-carbinol: Detection in vivo and enzyme induction in vitro
43. Drug interaction between St. John's wort and nevirapine
44. Metabolism of amprenavir in liver microsomes: Role of CYP3A4 inhibition for drug interactions
45. The chemopreventive agent diallyl sulfide. A structurally atypical phenobarbital-type inducer
46. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes
47. St. John's wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
48. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice
49. 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein
50. Chacterization of the in vitro biotransformation of the HIV-1 reverse transcriptase inhibitor nevirapine by human hepatic cytochromes P-450
51. Second thoughts about safety of St. John's wort
52. Herb-drug interactions: Potentially important but woefully under-researched
53. Possible interactions between synthetic and herbal medicinal products. Part I: Systematic review of indirect evidence
54. Influence of dietary components on the gastrointestinal metabolism and transport of drugs
55. Selective biotransformation of the human immunodeficiency virus protease inhibitor sequinavir by human small-intestinal cytochrome P4503A4 - Potential contribution to high first-pass metabolism
56. Herb-drug interactions
57. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance
58. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome-P450 isoforms
59. Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interaction
60. The CYP2D subfamily
61. St. John's wort (Hypericum perforatum): A review of the current pharmacological, toxicological, and clinical literature
62. Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals
63. Oxidation of 17α-ethynyloestradiol by human liver cytochrome P-450
64. Cytochrome P-450 3A4: Regulation and role in drug metabolism
65. Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: Properties of umbelliferous or citrus crude drugs and their relative prescriptions
66. Inhibitory effect of natural furanocoumarins on human microsomal cytochrome P450 3A activity
67. Liver subcellular fractions from rats treated by organosulfur compounds from Allium modulate mutagen activation
68. Modulation of phase II enzymes by organosulfur compounds form Allium vegetables in rat tissues
69. Induction of rat hepatic cytochrome P4501A and P4502B by the methoxsalen
70. Modification of hepatic drug-metabolizing enzymes in rats fed naturally occurring allyl sulphides
71. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice
72. Potential interactions between alternative therapies with warfarin
73. Effects of ginseng components on c-DNA expressed cytochrome P450 enzyme catalytic activity
74. Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential
75. Intestinal secretion of drugs. The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption
76. Nutritional modulation of cytochromes P450
77. Effect of diet and nutrition on the expression of cytochromes P450
78. Xenobiotic metabolism and bioactivation by cytochrome P-450
79. Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P-450
80. Interaction of drugs and Chinese herbs: Pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica
81. Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine (NDMA) metabolism and other monooxygenase activities
82. Metabolism of the chemopreventive agent diallyl sulphide to glutathione conjugates in rats
83. Interaction of St. John's wort extract with digoxin
84. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum)
85. St John's wort: A new alternative for depression?
86. Effects of dietary broccoli in human in vivo drug metabolizing enzymes: Evaluation of caffeine, oestrone and chlorzoxazone metabolism
87. Human P450 metabolism of warfarin
88. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid
89. Interaction of Hypericum perforatum (St. John's wort) with cyclosporin A metabolism in a patient after liver transplantation
90. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in the rat: Implications for drug-drug interaction
91. Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin
92. Human liver carbamazepine metabolism: Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation
93. Protection of rat liver microsomes against carbon tetrachloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition
94. Mechanism-based inactivation of cytochrome P450 2B1 by 8-methoxypsoralen and several other furanocoumarins
95. Mechanism-based inactivation of P450 2A6 by furanocoumarins
96. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4
97. Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites
98. Interaction between grapefruit juice and midazolam in humans
99. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man
100. Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allyl methylsulfide in rats
101. Metabolism of digoxin, digoxigenin digitoxosides and digoxigenin in human hepatocytes and liver-microsomes
102. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 in humans: Changes in caffeine metabolite ratios in response to controlled vegetable diets
103. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids
104. Effects of liquorice on the expression of UGT1A isozymes in rat hepatoma cells
105. Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicals
106. Grapefruit juice-simvastatin interaction; effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors
107. Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin
108. Effect of grapefruit dose on grapefruit juice-triazolam interaction
109. Use of alternative medicine by patients undergoing cardiac surgery
110. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats
111. Heterogeneous effects of anthraquinones on drug-metabolizing enzymes in the liver and small intestine of rat
112. Grapefruit juice increases felodipine oral bioavailability in humans by decreasing intestinal CYP3A protein expression
113. Relationship between the time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects
114. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulphoraphane in primary human and rat hepatocytes
115. Hazardous pharmacokinetic interaction of St John's wort (Hypericum perforatum) with the immunosuppressant cyclosporin
116. Effects of monoterpenoids on in vivo DMBA-DNA adduct formation and on phase I hepatic metabolizing enzymes
117. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers
118. The CYP3 family
119. Interaction of St. John's wort extract with phenprocoumon
120. Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats
121. St John's wort induces drug metabolism through activation of the pregnane X receptor
122. Naturally occurring organosulphur compounds as potential anticarcinogens
123. Toxicants in food: Naturally occurring
124. Low doses of diallyl sulfide, a compound derived from garlic, increase tissue activities of quinone reductase and glutathione transferase in the gastrointestinal tract of the rat
125. Potential metabolic interaction between St. John's wort and theophylline
126. Inhibition of cytochrome P450 enzymes by constituents of St John's wort, and herbal preparation used in the treatment of depression
127. Effects of bioflavonoids on hepatic P450 activities
128. Metabolism of the tricyclic antidepressant amitriptyline by cDNA-expressed human cytochrome P450 enzymes
129. Specificity of substrates and inhibitor probes for cytochrome cytochromes P450: Evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes
130. Stimulatory effects of vegetables on intestinal drug metabolism in the rat
131. Effects of brussel sprouts and cabbage on drug conjugation
132. Stimulatory effect of Brussel sprouts and cabbage on human drug metabolism
133. Effect of liquorice and glycyrrhizin on rat liver carcinogen metabolising enzymes
134. Effect of licorice and glycyrrhizin on murine liver CYP-dependent monooxygenases
135. The effects of nutrition on chemical toxicity
136. Indinavir concentrations and St John's wort
137. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone
138. Introducing complementary medicine into the medical curriculum
139. Auto- and hetero-induction with carbamazepine in man
140. Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds
141. St. John's wort: Effect on CYP3A4 activity
142. Interaction from herbal extract from St. John's wort with amitriptyline and its metabolites
143. Acute heart transplant rejection due to St John's wort
144. Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: Involvement of cytochrome P4503A
145. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents
146. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine A
147. More on oral contraceptives, drug interactions, herbal medicines, and hormone replacement therapy
148. Effect of licorice (Radix glycyrrhizae) on the pharmacokinetic (PK) and pharmacodynamics (PD) of midazolam in healthy subjects
149. Toxicants in food: Generated during cooking
150. Effects of green and black tea on hepatic xenobiotic metabolizing systems in male F344 rats
151. Seasonal variation in hypericin content of Hypericum perforatum L. (St John's wort)
152. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers
153. Vegetables, fruit and colon cancer in the Iowa Women's Health Study
154. 1 in the rat
155. Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects
156. Inhibition selectivity of grapefruit components on human cytochromes P450
157. Interactions between drugs and diet
158. Use and expenditure on complementary medicine in England; a population based survey
159. Effect of flavanone on mixed-function oxidase and conjugation reactions in rats
160. The importance of drug-transporting P-glycoproteins in toxicology
161. Induction of cytochrome P4501A1 in rat colon and liver by indole-3-carbinol and 5,6-benzoflavone
162. Induction of cytochrome P-450IA1, IA2, IIB1 and IIE1 by broccoli in rat liver and colon
163. Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: Dominance of CYP2C19 and 3A4
164. Nortriptyline E-10-hydroxylation in vitro is mediated by human CYP2D6 (high affinity) and CYP3A4 (low affinity): Implications for interactions with enzyme-inducing drugs
165. Milk thistle, a herbal supplement, decreases the activity of CYP3A4 and uridine diphosphoglucuronosyl transferase in human hepatocyte cultures
166. Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine
167. Triazolam biotransformation by human liver microsomes in vitro: Effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole
168. Toxicants in food: Fungal contaminants
169. Initiation and post-initiation chemopreventive effects of diallyl sulfide in esophageal carcinogenesis
170. St John's wort, a herbal antidepressant, activates the steroid X receptor
171. Herbal products: Active constituents, modes of action and quality control
172. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds
173. Effect of grapefruit juice on blood cyclosporin concentration
174. Chinese herbs and warfarin potentiation by 'Danshen'
175. Safety of St. John's wort (Hypericum perforatum)